Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197

Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization, for the production of an E.coli-expressed CRM197 conjugate vaccine carrier protein.

Scroll to Top